Plasma pro-surfactant protein B and lung function decline in smokers

European Respiratory Journal

Volumn 45, Issue 4, 2015, Pages 1037-1045

  Leung, Janice M ^a,b   Mayo, John ^a   Tan, Wan ^a,b   Tammemagi, C Martin ^c   Liu, Geoffrey ^d   Peacock, Stuart ^e,f   Shepherd, Frances A ^d   Goffin, John ^g   Goss, Glenwood ^h   Nicholas, Garth ⁱ   Tremblay, Alain ^j   Johnston, Michael ^k   Martel, Simon ^l   Laberge, Francis ^l   Bhatia, Rick ^m   Roberts, Heidi ^d   Burrowes, Paul ^j   Manos, Daria ⁿ   Stewart, Lori ^o   Gingras, Michel ^l   Pasian, Sergio ^l   Tsao, Ming Sound ^d   Lam, Stephen ^a,f   Sin, Don D ^a,b   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c BROCK UNIVERSITY   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e Canadian Centre for Applied Research in Cancer Control   (Canada)

^f BRITISH COLUMBIA CANCER AGENCY   (Canada)

^g Juravinsky Cancer Centre   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

ⁱ OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^j UNIVERSITY OF CALGARY   (Canada)

^k DALHOUSIE UNIVERSITY   (Canada)

^l LAVAL UNIVERSITY   (Canada)

^m MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

ⁿ QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^o HENDERSON GENERAL HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PRO SURFACTANT PROTEIN B; SURFACTANT PROTEIN B; UNCLASSIFIED DRUG; LUNG SURFACTANT; PRO-SFTPB PROTEIN, HUMAN; PROTEIN PRECURSOR; SURFACTANT ASSOCIATED PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RESPIRATORY AIRFLOW; SMOKING; ADVERSE EFFECTS; BLOOD; CANADA; COHORT ANALYSIS; FORCED EXPIRATORY FLOW; LUNG FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STATISTICAL MODEL;

AGED; BIOMARKERS; CANADA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY FLOW RATES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEIN PRECURSORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY;

EID: 84926443283     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00184214     Document Type: Article

References (33)

1. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013; 310: 591-608.
2. Dickens JA, Miller BE, Edwards LD, et al. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res 2011; 12: 146.
3. Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 2010; 11: 63.
4. Lomas DA, Silverman EK, Edwards LD, et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009; 34: 95-102.
5. Park HY, Churg A, Wright JL, et al. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188: 1413-1419.
6. Oosterlaken-Dijksterhuis MA, Haagsman HP, van Golde LM, et al. Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C. Biochemistry 1991; 30: 10965-10971.
7. Seeger W, Gunther A, Thede C. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants. Am J Physiol 1992; 262: L286-L291.
8. Ikegami M, Whitsett JA, Martis PC, et al. Reversibility of lung inflammation caused by SP-B deficiency. Am J Physiol Lung Cell Mol Physiol 2005; 289: L962-L970.
9. Miles PR, Bowman L, Rao KM, et al. Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. Am J Physiol 1999; 276: L186-L196.
10. Bersten AD, Hunt T, Nicholas TE, et al. Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure. Am J Respir Crit Care Med 2001; 164: 648-652.
11. Melton KR, Nesslein LL, Ikegami M, et al. SP-B deficiency causes respiratory failure in adult mice. Am J Physiol Lung Cell Mol Physiol 2003; 285: L543-L549.
12. Taguchi A, Politi K, Pitteri SJ, et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 2011; 20: 289-299.
13. Sin DD, Tammemagi CM, Lam S, et al. Pro-surfactant protein B as a biomarker for lung cancer prediction. J Clin Oncol 2013; 31: 4536-4543.
14. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013; 369: 910-919.
15. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011; 103: 1058-1068.
16. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
17. Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005; 2: 277-283.
18. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997; 169: 977-983.
19. COPDGene CT Workshop Group, Barr RG, Berkowitz EA, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD 2012; 9: 151-159.
20. Bewick V, Cheek L, Ball J. Statistics review 10: Further nonparametric methods. Crit Care 2004; 8: 196-199.
21. Bewick V, Cheek L, Ball J. Statistics review 8: Qualitative data - tests of association. Crit Care 2004; 8: 46-53.
22. Um SJ, Lam S, Coxson H, et al. Budesonide/formoterol enhances the expression of pro surfactant protein-B in lungs of COPD patients. PLoS One 2013; 8: e83881.
23. Winkler C, Atochina-Vasserman EN, Holz O, et al. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res 2011; 12: 29.
24. Doyle IR, Bersten AD, Nicholas TE. Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 1997; 156: 1217-1229.
25. Robin M, Dong P, Hermans C, et al. Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J 2002; 20: 1152-1161.
26. Clark JC, Wert SE, Bachurski CJ, et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995; 92: 7794-7798.
27. Nogee LM, Garnier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93: 1860-1863.
28. Baekvad-Hansen M, Nordestgaard BG, Dahl M. Heterozygosity for E292 V in ABCA3, lung function and COPD in 64,000 individuals. Respir Res 2012; 13: 67.
29. Baekvad-Hansen M, Dahl M, Tybjaerg-Hansen A, et al. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers. Am J Respir Crit Care Med 2010; 181: 17-20.
30. Clark JC, Weaver TE, Iwamoto HS, et al. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. Am J Respir Cell Mol Biol 1997; 16: 46-52.
31. Wert SE, Dey CR, Blair PA, et al. Increased expression of thyroid transcription factor-1 (TTF-1) in respiratory epithelial cells inhibits alveolarization and causes pulmonary inflammation. Dev Biol 2002; 242: 75-87.
32. Hannun YA, Obeid LM. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 2002; 277: 25847-25850.
33. Petrache I, Natarajan V, Zhen L, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005; 11: 491-498.